Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) General Pharmacology M212 Dr. Laila M. Matalqah Ph.D. Pharmacology.

Similar presentations


Presentation on theme: "Nonsteroidal Anti-inflammatory Drugs (NSAIDs) General Pharmacology M212 Dr. Laila M. Matalqah Ph.D. Pharmacology."— Presentation transcript:

1 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) General Pharmacology M212
Dr. Laila M. Matalqah Ph.D. Pharmacology

2 NSAIDs Analgesic (CNS and peripheral effect)
MOA: They act by inhibiting the cyclooxygenase enzymes that catalyze the first step in prostaglandin biosynthesis. The NSAIDs are a group of chemically dissimilar agents USES: Analgesic (CNS and peripheral effect) Antipyretic (Inhibit prostaglandin E2 within the area of the brain that controls temperature) Anti-inflammatory

3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Characteristics: Different chemical families Different pharmacokinetics and potency Common mechanism of action (cyclooxygenase inhibition) Different selectivity to COX-1 and COX-2 Common therapeutic indications Common adverse effects

4

5 Cell Membrane Phospholipids
Steroids Phospholipase A2 Arachidonic Acid NSAIDs Lipooxygenase COX) ) Cyclooxygenase Leukotrienes Prostaglandins (PG) Thromboxanes (TXN)

6 Pharmacological/Physiological Effects Platelets
Arachidonic Acid COX -1 COX -2 _ _ Platelet TXA2 Endothelial PGI2 ASPIRIN Vasoconstriction Platelet Aggregation Vasodilation Anti-Platelet Aggregation

7 cyclooxygenase Exists in the tissue as isoform (COX-1).
At site of inflammation, cytokines stimulate the induction of the 2nd isoform (COX-2). Inhibition of COX-2 is thought to be due to the anti- inflammatory actions of NSAIDs. Inhibition of COX-1 is responsible for their GIT toxicity.

8 Mechanism of Action inhibit cyclooxygenase: Result in inhibition of endogenous compounds synthesis known as“ PROSTAGLANDINS (PG) But, inhibition of PG synthase in gastric mucosa  cause GIT damage (dyspepsia, gastritis, ulcer)

9 Common Pharmacological Effects
Analgesic (CNS and peripheral effect) may involve non-PG related effects Antipyretic (CNS effect) Anti-inflammatory (except acetaminophen) due mainly to PG inhibition. Some shown to inhibit activation, aggregation, adhesion of neutrophils & release of lysosomal enzymes Some are Uricosuric

10 In what conditions are NSAIDs used?
To treat inflammation, mild to moderate pain, & fever Specific uses: headaches, arthritis, sports injuries, menstrual cramps (dysmenorrhea) Included in cold/allergy preparations 10

11 Common Adverse Effects
Gastritis and peptic ulceration with bleeding (inhibition of PG + other effects) Acute Renal Failure in susceptible patients Sodium + water retention and edema formation Prolongation of gestation and inhibition of labor GIT bleeding and perforation Hypersensitivity (not immunologic but due to PG inhibition)

12 selective COX-2 inhibitors
Celecoxib etoricoxib valdecoxib Have similar efficacies to that of the non-selective inhibitors, but the GIT side effects are decreased by ~50%.

13

14 The Salicylates - Aspirin
Aspirin (acetylsalicylic acid ) Hydrolyzed by esterases in tissues and blood to salicylate (active) and acetic acid. Duration of action ~ 4 hr. Orally taken. Weak acid (pKa ~ 3.5); so, it will be non-ionized in stomach  so, easily absorbed.

15 Pharmacokinetics of Aspirin

16 Aspirin - Therapeutic Uses
antiplatelet aggregation: Prophylaxis of diseases due to (CAD, post myocardial infarction, post stroke patients, post- operation. DVT) Analgesic : somatic; mild-moderate Antipyretic Anti-inflammatory : rheumatic fever, rheumatoid arthritis, other rheumatological diseases. High dose needed (5-8 g/day)

17 Pharmacological/Physiological Effects Platelets
ARACHIDONIC ACID COX -1 COX -2 _ _ Platelet TXA2 Endothelial PGI2 ASPIRIN Vasoconstriction Platelet Aggregation Vasodilation Anti-Platelet Aggregation

18 Aspirin Toxicity - Salicylism
tinnitus , dizziness , hearing impairment ( mg/l) Hyperpyrexia (>750mg/l) Confusion and drowsiness Sweating and hyperventilation Nausea, vomiting Marked acid-base disturbances Cardiovascular and respiratory collapse, coma convulsions and death

19 Other NSAID’s Phenylbutazone:
Additional uricosuric effect used for treatment of gout. Indomethacin: - ADR: CNS most common: halucinations, depression, seizures, contraindicated in children Ibuprofen : Better tolerated. Fewer side-effects Diclofenac sodium : high conc. in synovial fluid, used for rheumatoid arithritis

20 Other NSAID’s Piroxicam: Long-acting. Meloxicam:
COX-2 /COX-1 selectivity ratio of about 10 Ketorolac: equal efficacy to morphine in postoperative pain, approved for parenteral adminstration. Nabumetone: A prodrug, more potent COX-2 than COX-1

21 Selective COX-2 Inhibitors
Celecoxib,(Celebrex) Etoricoxib,(Arcoxia) Anti-inflammatory with less adverse effects, especially GI events Potential toxicities: increased risk of thrombotic events should not be given to patients with CV disease Role in Cancer prevention Role in Alzheimer’s disease

22 ACETAMINOPHEN “Paracetamol”

23 Acetaminophen Acetaminophen is NOT considered an NSAIDs because it lacks anti-inflammatory properties. Acetaminophen is similar to aspirin and other NSAIDs because it can reduce pain and fever (analgesic & antipyretic effects)

24 Actions of Acetaminophen
Antipyretics Efficacy similar to salicylates Inhibits prostaglandin synthetase in the hypothalamus (COX-3) Analgesia Relieves mild to moderate pain Efficacy equivalent to salicylates Inhibits brain prostaglandin synthetase Blocks pain impulses peripherally Peripheral action is blockade of Pain Impulse generation Less effect on peripheral enzyme Studies have shown that both apap and asa have equal effects on pain when given in equiv. Doses when the pain in non inflammatory in origin For inflammatory pain, salicylates are superior. They also inhibit prostaglandin synthetase peripherally, resulting in anti inflammatory activity.

25 Pharmacokinetics of Acetaminophen T1/2 = 2 hrs

26 Thank You


Download ppt "Nonsteroidal Anti-inflammatory Drugs (NSAIDs) General Pharmacology M212 Dr. Laila M. Matalqah Ph.D. Pharmacology."

Similar presentations


Ads by Google